Clonal lymphocytic populations in Philadelphia-negative chronic myeloproliferative disorders: is the T-cell clonality of ‘undetermined’ significance (TCUS) linked to a worse clinical outcome?

References

• World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, Lyon 2001
   Google Scholar
• Ruggeri M, Finazzi G, Tosetto A, Riva S, Rodeghiero F, Barbui T. No treatment for low-risk thrombocythaemia: results from a prospective study. Br J Haematol 1998; 103: 772–777
   PubMed Web of Science ®Google Scholar
• Guardiola P, Anderson J E, Bandini G, Cervantes F, Runde V, Arcese W, et al. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood 1999; 93: 2831–2838
   PubMed Web of Science ®Google Scholar
• Anderson J E, Tefferi A, Craig F, Holmberg L, Chauncey T, Appelbaum F R, et al. Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis. Blood 2001; 98: 586–593
   PubMed Web of Science ®Google Scholar
• Rozman C, Giralt M, Feliu E, Rubio D, Cortes M T. Life expectancy of patients with chronic nonleukemic myeloproliferative disorders. Cancer 1991; 67: 2658–2663
   PubMed Web of Science ®Google Scholar
• Tefferi A. The Philadelphia chromosome negative chronic myeloproliferative disorders: a practical overview. Mayo Clin Proc 1998; 73: 1177–1184
   PubMed Web of Science ®Google Scholar
• Brodmann S, Passweg J R, Gratwohl A, Tichelli A, Skoda R C. Myeloproliferative disorders: complications, survival and causes of death. Ann Hematol 2000; 79: 312–318
   PubMed Web of Science ®Google Scholar
• Tefferi A, Gilliland D G. The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: status report and immediate implications for disease classification and diagnosis. Mayo Clin Proc 2005; 80: 947–958
   PubMed Web of Science ®Google Scholar
• Macintyre E A, Delabesse E. Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semin Hematol 1999; 36: 373–389
   PubMed Web of Science ®Google Scholar
• Collins R D. Is clonality equivalent to malignancy: specifically, is immunoglobulin gene rearrangement diagnostic of malignant lymphoma?. Hum Pathol 1997; 28: 850–861
   PubMed Web of Science ®Google Scholar
• Bauermeister D E. Quantitation of bone marrow reticulin – a normal range. Am J Clin Pathol 1971; 56: 24–31
   PubMed Web of Science ®Google Scholar
• Miettinen M, Lasota J. Polymerase chain reaction based gene rearrangement studies in the diagnosis of follicular lymphoma – performance in formaldehyde-fixed tissue and application in clinical problem cases. Pathol Res Pract 1997; 193: 9–19
   PubMed Web of Science ®Google Scholar
• Wan J H, Trainor K J, Brisco M J, Morley A A. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990; 43: 888–890
   PubMed Web of Science ®Google Scholar
• Rakozy C K, Mohamed A N, Vo T D, Khatib G, Long P M, Eilender D, et al. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse. Am J Clin Pathol 2001; 116: 168–176
   PubMed Web of Science ®Google Scholar
• Dadej K, Gaboury L, Lamarre L, Petorin C, Seguin C, Cadotte M, et al. The value of clonality in the diagnosis and follow-up of patients with cutaneous T-cell infiltrates. Diagn Mol Pathol 2001; 10: 78–88
   PubMed Web of Science ®Google Scholar
• Hallen J. Frequency of ‘abnormal’ serum globulins (M-components) in the aged. Acta Med Scand 1963; 173: 737–744
   PubMed Web of Science ®Google Scholar
• Aman P, Mellstedt H. The leukemic B-cell population of patients with monoclonal lymphocytosis of undetermined significance (MLUS) are functionally distinct from the chronic lymphocytic leukemia (CLL) derived cell population. Leuk Res 1991; 15: 715–719
   PubMed Web of Science ®Google Scholar
• Marti G E, Rawstron A C, Ghia P, Hillmen P, Houlston R S, Kay N, et al. The International Familial CLL Consortium. Diagnostic criteria for monoclonal B-cell lymphocytosis. Br J Haematol 2005; 130: 325–332
   PubMed Web of Science ®Google Scholar
• Posnett D N, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to ‘benign monoclonal gammapathy’. J Exp Med 1994; 179: 609–618
   PubMed Web of Science ®Google Scholar
• Lantelme E, Granziero L, Angman L, Giachino C. Clonal predominance, but preservation of a polyclonal reservoir, in the normal alpha beta T-cell repertoire. Hum Immunol 1997; 53: 49–56
   PubMed Web of Science ®Google Scholar
• Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth J A, Sinclair A J, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol 2002; 169: 1984–1992
   PubMed Web of Science ®Google Scholar
• Delfau-Larue M H. Peripheral blood T-cell clonality of no cutaneous T-cell lymphoma diagnostic value. Blood 2001; 98: 248
   PubMed Web of Science ®Google Scholar
• Schwab R, Szabo P, Manavalan J S, Weksler M E, Posnett D N, Pannetier C, et al. Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997; 158: 4493–4499
   PubMed Web of Science ®Google Scholar
• Monteiro J, Hingorani R, Choi I H, Silver J, Pergolizzi R, Gregersen P K. Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins: implications for studies of infectious and autoimmune diseases. Mol Med 1995; 1: 614–624
   PubMed Web of Science ®Google Scholar
• Fitzgerald J E, Ricalton N S, Meyer A C, West S G, Kaplan H, Behrendt C, et al. Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995; 154: 3538–3547
   PubMed Web of Science ®Google Scholar
• Manfras B J, Weidenbach H, Beckh K H, Kern P, Moller P, Adler G, et al. Oligoclonal CD8+ T-cell expansion in patients with chronic hepatitis C is associated with liver pathology and poor response to interferon-alpha therapy. J Clin Immunol 2004; 24: 258–271
   PubMed Web of Science ®Google Scholar
• Rittner H L, Zettl A, Jendro M C, Bartz-Bazzanella P, Goronzy J J, Weyand C M. Multiple mechanisms support oligoclonal T-cell expansion in rheumatoid synovitis. Mol Med 1997; 3: 452–465
   PubMed Web of Science ®Google Scholar
• Plonquet A, Gherardi R K, Creange A, Antoine J C, Benyahia B, Grisold W, et al. Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome. J Neuroimmunol 2002; 122: 100–105
   Google Scholar
• Risitano A M, Maciejewski J P, Green S, Plasilova M, Zeng W, Young N S. In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing. Lancet 2004; 364: 355–364
   PubMed Web of Science ®Google Scholar
• Delfau-Larue M H, Laroche L, Wechsler J, Lepage E, Lahet C, Asso-Bonnet M, et al. Diagnostic value of dominant T-cell clones in peripheral blood in 363 patients presenting consecutively with a clinical suspicion of cutaneous lymphoma. Blood 2000; 96: 2987–2992
   PubMed Web of Science ®Google Scholar
• Gniadecki R, Lukowsky A. Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma. Arch Dermatol 2005; 141: 361–367
   PubMed Web of Science ®Google Scholar
• Gherardi R K, Farcet J P, Creange A, Claudepierre P, Malapert D, Authier F J, et al. Dominant T-cell clones of unknown significance in patients with idiopathic sensory neuropathies. Neurology 1998; 51: 384–389
   PubMed Web of Science ®Google Scholar
• Serrano D, Becker K, Cunningham-Rundles C, Mayer L. Characterization of the T cell receptor repertoire in patients with common variable immunodeficiency: oligoclonal expansion of CD8(+) T cells. Clin Immunol 2000; 97: 248–258
   PubMed Web of Science ®Google Scholar
• Isobe T, Tanimoto T E, Nakaji G, Miyamoto T, Yamasaki S, Takase K, Numata A, et al. Autoimmune thrombocytopenia with clonal expansion of CD8-positive T cells after autologous peripheral blood stem cell transplantation for diffuse large B-cell lymphoma. Bone Marrow Transplant 2005; 35: 315–316
   PubMed Web of Science ®Google Scholar
• Matsutani T, Ohashi Y, Yoshioka T, Tsuruta Y, Doi H, Satomi S, et al. Skew in T-cell receptor usage and clonal T-cell expansion in patients with chronic rejection of transplanted kidneys. Transplantation 2003; 75: 398–407
   PubMed Web of Science ®Google Scholar
• Serrano D, Monteiro J, Allen S L, Kolitz J, Schulman P, Lichtman S M, et al. Clonal expansion within the CD4 + CD57+ and CD8 + CD57+ T cell subsets in chronic lymphocytic leukemia. J Immunol 1997; 158: 1482–1489
   PubMed Web of Science ®Google Scholar
• Alatrakchi N, Farace F, Frau E, Carde P, Munck J N, Triebel F. T-cell clonal expansion in patients with B-cell lymphoproliferative disorders. J Immunother 1998; 21: 363–370
   PubMed Web of Science ®Google Scholar
• Epperson D E, Nakamura R, Saunthararajah Y, Melenhorst J, Barrett A J. Oligoclonal T cell expansion in myelodysplastic syndrome: evidence for an autoimmune process. Leuk Res 2001; 25: 1075–1083
   PubMed Web of Science ®Google Scholar
• Dhodapkar M V, Li C Y, Lust J A, Tefferi A, Phyliky R L. Clinical spectrum of clonal proliferations of T-large granular lymphocytes: a T-cell clonopathy of undetermined significance?. Blood 1994; 84: 1620–1627
   PubMed Web of Science ®Google Scholar
• Dippel E, Klemke D, Hummel M, Stein H, Goerdt S. T-cell clonality of undetermined significance. Blood 2001; 98: 247–248
   PubMed Web of Science ®Google Scholar
• Macdonald D, Reiter A, Cross N C. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101–107
   PubMed Web of Science ®Google Scholar
• Hernandez-Boluda J C, Cervantes F, Alvarez A, Lopez-Guillermo A, Montserrat E. Non-Hodgkin's lymphoma following untreated essential thrombocythemia. Leuk Lymphoma 2000; 36: 421–423
   PubMed Web of Science ®Google Scholar
• Baxter E J, Scott L M, Campbell P J, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365: 1054–1061
   PubMed Web of Science ®Google Scholar
• James C, Ugo V, Le Couedic J P, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434: 1144–1148
   PubMed Web of Science ®Google Scholar
• Reeder T L, Bailey R J, Dewald G W, Tefferi A. Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia. Blood 2003; 101: 1981–1983
   PubMed Web of Science ®Google Scholar
• Lenz H J, Waller H D. Autoimmune hemolytic anemia in a patient with polycythemia vera: first description. Acta Haematol 1991; 85: 111
   PubMed Web of Science ®Google Scholar
• Szegedi G, Nagy G. Coincidence of autoimmune diseases and polycythemia vera. Haematologia (Budap) 1970; 4: 367–372
   PubMedGoogle Scholar
• Duhrsen U, Augener W, Zwingers T, Brittinger G. Spectrum and frequency of autoimmune derangements in lymphoproliferative disorders: analysis of 637 cases and comparison with myeloproliferative diseases. Br J Haematol 1987; 67: 235–239
   PubMed Web of Science ®Google Scholar